
Gastrointestinal (GI) and colorectal cancers affect vital organs involved in digestion, including the stomach, intestines, liver, pancreas, and colon. These cancers can significantly impact overall health, but with modern diagnostic tools and advanced treatment options, outcomes have improved dramatically.
At Max Hospital, Dwarka, under the expert guidance of Dr. Peush Bajpai, Director & Unit Head, Medical Oncology, patients receive comprehensive, personalised treatment for all types of GI and colorectal cancers. Using the latest approaches such as targeted therapy, immunotherapy, chemotherapy, and precision oncology, Dr. Bajpai and his team deliver care focused on long-term survival and quality of life.
These include cancers that affect the digestive system, such as:
Colorectal cancer begins in the colon or rectum and is one of the most common cancers worldwide. It often starts as noncancerous polyps that can turn malignant over time if not detected early.
Symptoms vary depending on the affected organ but may include:
Early detection through screening and genetic testing plays a crucial role in improving outcomes.
At Max Hospital, Dwarka, diagnosis begins with a detailed evaluation to determine the exact location, stage, and molecular profile of the cancer. Diagnostic methods include:
Dr. Peush Bajpai believes in personalised, multimodal treatment, combining the most effective therapies to achieve optimal results.
Surgical removal of the tumour is often the first-line treatment for localised cancers. Minimally invasive or robotic techniques are used whenever possible for faster recovery.
Uses anti-cancer drugs to destroy or inhibit the growth of cancer cells. It may be used before (neoadjuvant) or after (adjuvant) surgery, or for advanced cases.
Designed to attack cancer cells that carry specific genetic mutations or molecular markers, sparing healthy tissue. Examples include drugs targeting EGFR, VEGF, or HER2.
Activates the body’s immune system to recognise and destroy cancer cells. Particularly effective in MSI-high or mismatch repair-deficient colorectal cancers.
Used primarily for rectal and esophageal cancers to shrink tumours before surgery or to relieve symptoms in advanced disease.
Dr. Bajpai integrates advanced genomic testing and molecular analysis to craft tailor-made treatment plans unique to each patient’s cancer biology.
These advanced treatment options are suitable for patients with:
Each patient undergoes a thorough evaluation with Dr. Peush Bajpai to ensure treatment safety and effectiveness.
Q1. Are GI and colorectal cancers curable?
Yes. Early-stage cancers can often be completely cured with surgery and supportive treatments. Advanced stages can be effectively controlled with modern therapies.
Q2. Is genetic testing necessary for treatment planning?
Absolutely. Genetic and molecular profiling helps identify mutations that can be targeted with specific drugs, improving outcomes.
Q3. Can immunotherapy help in GI cancers?
Yes. Immunotherapy has shown significant success in certain colorectal, gastric, and liver cancers with specific biomarkers.
Q4. What are the common side effects of treatment?
Depending on the treatment, side effects may include fatigue, nausea, appetite loss, or mild immune-related effects. Dr. Bajpai’s team provides comprehensive supportive care to manage these.
If you or your loved one has been diagnosed with a gastrointestinal or colorectal cancer, timely treatment can make all the difference.
Consult Dr. Peush Bajpai, Director & Unit Head, Medical Oncology at Max Hospital, Dwarka, for advanced, personalised cancer treatment that combines global expertise with compassionate care.
Take control of your health with evidence-based, precision-driven oncology.
Expert oncology care focused on hope, healing, and better outcomes.
Visit us on Mon–Sat, 9 AM to 5 PM.
© 2025 | Dr. Peush Bajpai | All rights reserved | Digital Marketing by Remedo